Patents by Inventor Renee Tsolis

Renee Tsolis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release vaccines and methods of treating diseases and disorders
    Patent number: 11975060
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Grant
    Filed: January 18, 2021
    Date of Patent: May 7, 2024
    Assignee: The Texas A&M University System
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams, Angela M. Arenas-Gamboa
  • Controlled Release Vaccines and Methods of Treating Brucella Diseases and Disorders
    Publication number: 20210386848
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Application
    Filed: January 18, 2021
    Publication date: December 16, 2021
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams, Angela M. Arenas-Gamboa
  • Controlled release vaccines and methods for treating diseases and disorders
    Patent number: 10940193
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: March 9, 2021
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams, Angela M. Arenas-Gamboa
  • Controlled Release Vaccines and Methods of Treating Brucella Diseases and Disorders
    Publication number: 20190142923
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 16, 2019
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams, Angela M. Arenas-Gamboa
  • Controlled release vaccines and methods of treating diseases and disorders
    Patent number: 10220084
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: March 5, 2019
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams
  • Controlled Release Vaccines and Methods of Treating Brucella Diseases and Disorders
    Publication number: 20160095913
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 7, 2016
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams
  • Controlled release vaccines and methods for treating diseases and disorders
    Patent number: 9248176
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: February 2, 2016
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Thomas A. Ficht, Allison R. Ficht, Renee Tsolis, Leslie Garry Adams
  • CONTROLLED RELEASE VACCINES AND METHODS FOR TREATING BRUCELLA DISEASES AND DISORDERS
    Publication number: 20140248354
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Application
    Filed: October 7, 2011
    Publication date: September 4, 2014
    Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Thomas A. Ficht, Allison Ficht, Renee Tsolis, Leslie Garry Adams